Bosch TM - Search Results

1

The added value of H₂ antagonists in premedication regimens during paclitaxel treatment.

Cox JM, van Doorn L, Malmberg R, Oomen-de Hoop E, Bosch TM, van den Bemt PMLA, Boere IA, Jager A, Mathijssen RHJ, van Leeuwen RWF. Cox JM, et al. Among authors: bosch tm. Br J Cancer. 2021 May;124(10):1647-1652. doi: 10.1038/s41416-021-01313-0. Epub 2021 Mar 24. Br J Cancer. 2021. PMID: 33762718 Free PMC article. Clinical Trial.

2

Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093).

Kuppens IE, Bosch TM, van Maanen MJ, Rosing H, Fitzpatrick A, Beijnen JH, Schellens JH. Kuppens IE, et al. Among authors: bosch tm. Cancer Chemother Pharmacol. 2005 Jan;55(1):72-8. doi: 10.1007/s00280-004-0864-4. Epub 2004 Aug 17. Cancer Chemother Pharmacol. 2005. PMID: 15316750 Clinical Trial.

3

[Overdosing of pipamperone from a squeeze bottle].

de Roo JHC, Bosch TM, van Rhijn A, Del Canho R. de Roo JHC, et al. Among authors: bosch tm. Ned Tijdschr Geneeskd. 2018;162:D2160. Ned Tijdschr Geneeskd. 2018. PMID: 29543144 Dutch.

4

Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Bosch TM, Meijerman I, Beijnen JH, Schellens JH. Bosch TM, et al. Clin Pharmacokinet. 2006;45(3):253-85. doi: 10.2165/00003088-200645030-00003. Clin Pharmacokinet. 2006. PMID: 16509759 Review.

5

Screening for polymorphisms in the PXR gene in a Dutch population.

Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Bosch TM, et al. Eur J Clin Pharmacol. 2006 May;62(5):395-9. doi: 10.1007/s00228-006-0108-0. Epub 2006 Mar 28. Eur J Clin Pharmacol. 2006. PMID: 16568343

6

Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancer.

Beumer JH, Rademaker-Lakhai JM, Rosing H, Hillebrand MJ, Bosch TM, Lopez-Lazaro L, Schellens JH, Beijnen JH. Beumer JH, et al. Among authors: bosch tm. Cancer Chemother Pharmacol. 2007 May;59(6):825-37. doi: 10.1007/s00280-006-0342-2. Epub 2006 Sep 20. Cancer Chemother Pharmacol. 2007. PMID: 16988825

7

Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.

Joerger M, Bosch TM, Doodeman VD, Beijnen JH, Smits PH, Schellens JH. Joerger M, et al. Among authors: bosch tm. Eur J Clin Pharmacol. 2006 Aug;62(8):681-4. doi: 10.1007/s00228-006-0162-7. Epub 2006 Jun 24. Eur J Clin Pharmacol. 2006. PMID: 16799820

8

Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population.

Bosch TM, Kjellberg LM, Bouwers A, Koeleman BP, Schellens JH, Beijnen JH, Smits PH, Meijerman I. Bosch TM, et al. Am J Pharmacogenomics. 2005;5(2):123-31. doi: 10.2165/00129785-200505020-00005. Am J Pharmacogenomics. 2005. PMID: 15813675

9

Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.

Bosch TM, Doodeman VD, Smits PH, Meijerman I, Schellens JH, Beijnen JH. Bosch TM, et al. Mol Diagn Ther. 2006;10(3):175-85. doi: 10.1007/BF03256456. Mol Diagn Ther. 2006. PMID: 16771603

10

Rapid detection of the DPYD IVS14+1G>A mutation for screening patients to prevent fluorouracil-related toxicity.

Bosch TM, Bakker R, Schellens JH, Cats A, Smits PH, Beijnen JH. Bosch TM, et al. Mol Diagn Ther. 2007;11(2):105-8. doi: 10.1007/BF03256229. Mol Diagn Ther. 2007. PMID: 17397246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page